0001209191-21-057057.txt : 20210921
0001209191-21-057057.hdr.sgml : 20210921
20210921170459
ACCESSION NUMBER: 0001209191-21-057057
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210604
FILED AS OF DATE: 20210921
DATE AS OF CHANGE: 20210921
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HERSHBERG ROBERT
CENTRAL INDEX KEY: 0001274139
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39756
FILM NUMBER: 211267103
MAIL ADDRESS:
STREET 1: 3005 FIRST AVENUE
CITY: SEATTLE
STATE: WA
ZIP: 98121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Silverback Therapeutics, Inc.
CENTRAL INDEX KEY: 0001671858
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 811489190
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 FAIRVIEW AVENUE NORTH, SUITE 600
CITY: SEATTLE
STATE: WA
ZIP: 98109
BUSINESS PHONE: 206-456-2900
MAIL ADDRESS:
STREET 1: 500 FAIRVIEW AVENUE NORTH, SUITE 600
CITY: SEATTLE
STATE: WA
ZIP: 98109
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-04
0
0001671858
Silverback Therapeutics, Inc.
SBTX
0001274139
HERSHBERG ROBERT
C/O SILVERBACK THERAPEUTICS, INC.
500 FAIRVIEW AVENUE N, SUITE 600
SEATTLE
WA
98109
1
0
0
0
Stock Option (right to buy)
28.83
2021-06-04
4
A
0
15000
0.00
A
2031-06-03
Common Stock
15000
15000
D
The shares subject to the option vest on the earlier of June 4, 2022 or the date of the 2022 annual meeting of the Issuer's stockholders which date has not been set by the Issuer's Board of Directors.
/s/ Jeffrey C. Pepe, Attorney-in-Fact
2021-09-21